Across Protocol vs Mitosis — how do they compare? Across Protocol trades at Rp731.24 (market cap Rp505,3M, Rp188,8M 24h volume), while Mitosis trades at Rp455.08 (market cap Rp82,1M, Rp73,7M 24h volume). The key difference: Across Protocol is far larger — about 6.2× Mitosis's market cap, and Across Protocol 's circulating supply is 716,5M / 1B ACX (72%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 57 Days and Mitosis for 20 Days on average.
| ACX | MITO | |
|---|---|---|
Market Cap | Rp505,3M | Rp82,1M |
Volume (24h) | Rp188,8M | Rp73,7M |
Circulating Supply | 716,5M / 1B ACX (72%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 57 Days | 20 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →